Subtype
Prostate Neoplasm
CI-CAN-00003778Explore in graph →
Non-malignant1,453 active trials24 approved drugs58 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003778Explore in graph →
Clinical trials
6,544 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00004014 | Liposomal Doxorubicin in Treating Patients With Prostate Cancer | completed | Phase 2 | 10 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 16, 2010 | clinicaltrials |
| NCT00152919 | Mobicox: Study of Meloxicam to Reduce Prostate Swelling in Permanent Seed Prostate Brachytherapy | completed | Phase 3 | 100 | University Health Network, TorontoOTHER | 1 | Aug 13, 2010 | clinicaltrials |
| NCT00160953 |
| Endorectal Coil Magnetic Resonance Images (ERC-MRI) |
| completed |
| Phase 2 |
| 20 |
| University Health Network, TorontoOTHER |
| 1 |
| Aug 11, 2010 |
| clinicaltrials |
| NCT00252447 | Preop Conformal Radiotherapy - Prostate | completed | Phase 1 / Phase 2 | 15 | University Health Network, TorontoOTHER | 1 | Aug 11, 2010 | clinicaltrials |
| NCT01168323 | Spaced Education to Optimize Prostate Cancer Screening | completed | N/A | 95 | Harvard University Faculty of MedicineOTHER | 1 | Aug 9, 2010 | clinicaltrials |
| NCT00982800 | Does Postoperative Gabapentin Reduce Pain, Opioid Consumption and Anxiety and Have a Positive Effect on Health Related Quality of Life After Radical Prostatectomy? | completed | Phase 4 | 60 | Sunnybrook Health Sciences CentreOTHER | 1 | Aug 6, 2010 | clinicaltrials |
| NCT00430235 | A Study of BAY 43-9006 in Combination With Bicalutamide in Patients With Chemo-Naïve Hormone Refractory Prostate Cancer | completed | Phase 2 | 39 | British Columbia Cancer AgencyOTHER | 1 | Aug 5, 2010 | clinicaltrials |
| NCT00193193 | Weekly Paclitaxel, Low-Dose Estramustine, and Carboplatin in the Treatment of Hormone Refractory Prostate Carcinoma | completed | Phase 2 | 100 | SCRI Development Innovations, LLCOTHER | 0 | Aug 4, 2010 | clinicaltrials |
| NCT01173952 | Quality of Life in Men Undergoing Robotic Assisted Laparoscopic Radical Prostatectomy Versus Radical Retropubic Prostatectomy | unknown | — | 350 | Samsung Medical CenterOTHER | 0 | Aug 2, 2010 | clinicaltrials |
| NCT00193232 | Weekly Docetaxel and Bortezomib in the Treatment of Advanced Hormone-Refractory Prostate Cancer | completed | Phase 2 | 50 | SCRI Development Innovations, LLCOTHER | 0 | Jul 28, 2010 | clinicaltrials |
| NCT01168141 | Window Study of ZD4054 in Metastatic Prostate Cancer | unknown | N/A | 30 | The Christie NHS Foundation TrustOTHER | 1 | Jul 23, 2010 | clinicaltrials |
| NCT00242060 | Functional and Morphologic MRI in the Detection of Prostate Cancer in Patients With Prior Negative Biopsy | completed | N/A | — | University Health Network, TorontoOTHER | 1 | Jul 15, 2010 | clinicaltrials |
| NCT01025479 | Prevalence of Osteoporosis in Korean Prostate Cancer Patients Who is Receiving LHRH Agonist and/or Anti-androgen Agent | completed | — | 829 | AstraZenecaINDUSTRY | 1 | Jun 30, 2010 | clinicaltrials |
| NCT00269555 | Effects of GCP on Prostate Cancer. | completed | N/A | 62 | University of California, DavisOTHER | 1 | Jun 29, 2010 | clinicaltrials |
| NCT00855647 | Hypofractionated Radiotherapy for Localized Prostate Cancer (With CyberKnife or With IMRT) | completed | Phase 2 | 99,999 | Stanford UniversityOTHER | 1 | Jun 3, 2010 | clinicaltrials |
| NCT00305929 | Study of WST09 in Prostate Cancer After Radiation: Repeat Procedure | completed | Phase 2 | 8 | STEBA FranceINDUSTRY | 1 | Jun 2, 2010 | clinicaltrials |
| NCT00312442 | Phase II/III Study of WST09 in Prostate Cancer After Radiation Therapy | terminated | Phase 2 / Phase 3 | 16 | STEBA FranceINDUSTRY | 1 | Jun 2, 2010 | clinicaltrials |
| NCT00181558 | Atrasentan and Zometa for Men With Prostate Cancer Metastatic to Bone | completed | Phase 2 | 44 | Massachusetts General HospitalOTHER | 1 | May 10, 2010 | clinicaltrials |
| NCT00681694 | Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer | unknown | — | 414 | Massachusetts General HospitalOTHER | 1 | Apr 28, 2010 | clinicaltrials |
| NCT00258765 | Adjuvant Docetaxel-Zoledronic Acid in High-risk Early Prostate Cancer Following Prostatectomy. | terminated | Phase 2 | 1 | Novartis PharmaceuticalsINDUSTRY | 1 | Apr 26, 2010 | clinicaltrials |
| NCT00871585 | Evaluation of Prostate-Specific Antigen (PSA) Levels in Patients With Advanced Prostate Cancer Treated With Bicalutamide | completed | — | 340 | AstraZenecaINDUSTRY | 1 | Apr 15, 2010 | clinicaltrials |
| NCT00908674 | Androcur Effects on Quality of Life | completed | — | 245 | BayerINDUSTRY | 1 | Apr 13, 2010 | clinicaltrials |
| NCT00557037 | A Phase II Trial of Phenoxodiol in Patients With Castrate and Non-Castrate Prostate Cancer | completed | Phase 2 | 60 | MEI Pharma, Inc.INDUSTRY | 1 | Apr 8, 2010 | clinicaltrials |
| NCT01089881 | The Effectiveness of 18F-fluorocholine Positron Emission Tomography (PET) in Detecting, Staging and Following-up Prostate Cancer | unknown | — | 150 | National Taiwan University HospitalOTHER | 1 | Mar 19, 2010 | clinicaltrials |
| NCT00003307 | Radiation Therapy Plus Amifostine in Treating Patients With Primary Prostate Cancer | completed | Phase 2 | 25 | University of ArizonaOTHER | 1 | Mar 16, 2010 | clinicaltrials |
| NCT01086683 | Rehabilitation of Cancer Survivors in Denmark: The Effect of a Psychosocial Rehabilitation Course | completed | Phase 2 / Phase 3 | 513 | Danish Cancer SocietyOTHER | 1 | Mar 15, 2010 | clinicaltrials |
| NCT00048841 | Prevention of Osteoporosis in Men With Prostate Cancer | completed | Phase 3 | 112 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Mar 2, 2010 | clinicaltrials |
| NCT00415779 | ZANTE: Zometa and Taxotere in Hormone Refractory Prostate Cancer(ZANTE) | completed | Phase 1 | 36 | National Cancer Institute, NaplesOTHER | 1 | Feb 24, 2010 | clinicaltrials |
| NCT00909558 | Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer | suspended | Phase 1 | 24 | Envita Medical Center, Inc.INDUSTRY | 1 | Feb 24, 2010 | clinicaltrials |
| NCT00084526 | Computed Tomography (CT) Scans Using CT-On-Rails™ to Pinpoint the Location of the Tumor in Treating Patients With Prostate Cancer | completed | Phase 1 / Phase 2 | 40 | Fox Chase Cancer CenterOTHER | 1 | Feb 12, 2010 | clinicaltrials |
| NCT00166478 | Exisulind Prior to Radical Prostatectomy | completed | Phase 2 | 130 | Mayo ClinicOTHER | 1 | Jan 28, 2010 | clinicaltrials |
| NCT00523484 | Casodex/Zoladex Hormonal therApy Study for assessMent of Correlation Between PSA & BAI in prOstate Cancer patieNts(CHAMPION) | completed | — | 1,200 | AstraZenecaINDUSTRY | 1 | Jan 26, 2010 | clinicaltrials |
| NCT00811876 | Retrospective, Non-interventional Study of Depo-Eligard®.(OCT) | completed | — | 140 | Astellas Pharma IncINDUSTRY | 1 | Jan 22, 2010 | clinicaltrials |
| NCT00196807 | Prostate Cancer Screening: Fostering Informed Decisions | completed | Phase 3 | 543 | Georgetown UniversityOTHER | 1 | Jan 20, 2010 | clinicaltrials |
| NCT00422708 | Local Anesthesia for Prostate Biopsy | completed | Phase 4 | 243 | Mayo ClinicOTHER | 1 | Jan 20, 2010 | clinicaltrials |
| NCT00196781 | Treatment Decision Making in Early-Stage Prostate Cancer | completed | Phase 3 | 168 | Georgetown UniversityOTHER | 1 | Jan 13, 2010 | clinicaltrials |
| NCT00176527 | Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy | terminated | Phase 2 | 40 | University of Medicine and Dentistry of New JerseyOTHER | 1 | Dec 11, 2009 | clinicaltrials |
| NCT00134706 | A Study of Docetaxel Plus Carboplatin in Patients With Hormone Refractory Prostate Cancer | completed | Phase 2 | 30 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 9, 2009 | clinicaltrials |
| NCT00136487 | Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer | completed | Phase 2 / Phase 3 | 85 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 9, 2009 | clinicaltrials |
| NCT00140478 | Mifepristone (RU-486) in Androgen Independent Prostate Cancer | completed | Phase 2 | 48 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 9, 2009 | clinicaltrials |
| NCT00165386 | MRI-guided Bone Marrow Biopsies of Prostate Cancer Patients | completed | N/A | 20 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 9, 2009 | clinicaltrials |
| NCT00268710 | Docetaxel in Hormone Refractory Prostate Cancer (HRPC)[Weekly or 3weekly TAX + Prednisone in HRPC] | completed | Phase 2 | — | SanofiINDUSTRY | 0 | Dec 7, 2009 | clinicaltrials |
| NCT00280098 | Docetaxel in the Treatment of Hormone Refractory Prostate Cancer | completed | Phase 4 | 30 | SanofiINDUSTRY | 1 | Dec 7, 2009 | clinicaltrials |
| NCT00035997 | Open-label Trial on the Effect of I.V. Zoledronic Acid 4 mg on Bone Density in Hormone Sensitive Prostate Cancer Patients With Bone Metastasis | completed | Phase 4 | 261 | Novartis PharmaceuticalsINDUSTRY | 1 | Nov 23, 2009 | clinicaltrials |
| NCT00087659 | A Prostate Cancer Study in Men Undergoing Androgen Deprivation Therapy | completed | N/A | — | Novartis PharmaceuticalsINDUSTRY | 1 | Nov 23, 2009 | clinicaltrials |
| NCT00391950 | Maintaining Bone Strength in Men With Prostate Cancer | terminated | Phase 3 | 300 | NovartisINDUSTRY | 1 | Nov 23, 2009 | clinicaltrials |
| NCT00166725 | Effects of Octreotide Acetate on Circulating Levels of Chromogranin A in Advanced Prostate Cancer Patients | completed | Phase 2 | 40 | NovartisINDUSTRY | 1 | Nov 19, 2009 | clinicaltrials |
| NCT00166426 | Exisulind Versus Placebo After Surgical Removal of the Prostate | completed | Phase 2 | 240 | Mayo ClinicOTHER | 1 | Nov 16, 2009 | clinicaltrials |
| NCT01006564 | Multifunctional Magnetic Resonance (MR) for Radiotherapy Planning in Prostate Cancer | unknown | N/A | 30 | Royal Marsden NHS Foundation TrustOTHER | 1 | Nov 3, 2009 | clinicaltrials |
| NCT00139191 | Study Evaluating the Correlation Between C-11 Acetate Uptake and Retention as Measured by PET and FAS in Prostate Cancer | completed | N/A | 20 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 2, 2009 | clinicaltrials |
Data updated 22 days agoSource updated Aug 16, 2010source: clinicaltrials